Company: PIII
Filing Date: 2025-04-17
Form Type: 8-K
Source: 0001628280-25-018083
Chunk: 2

Company: P3 Health Partners Inc.
Filing Date: 2025-04-17
Form: 8-K
Item: Item 5.03
Chunk 2
---
 the Effective Date. Proportional adjustments will be made to the number of shares of Class A common stock underlying the Company’s outstanding equity awards and warrants, as well as the exercise or conversion price, as applicable, and to the number of shares issuable under the Company’s equity incentive plans and other existing agreements.

The Company's Class A common stock began trading on a split-adjusted basis on The Nasdaq Capital Market at the commencement of trading on April 14, 2025 under the Company's existing trading symbol "PIII". The new CUSIP number for the Class A common stock following the Reverse Stock Split is 744413 204. The Company’s public warrants continue to trade on Nasdaq under the ticker symbol “ PIIIW” with the existing CUSIP number.

The foregoing description is qualified in its entirety by the full text of the Charter Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report on Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the trading of the Class A common stock on a split-adjusted basis and the impact of the Reverse Stock Split, including any adjustments from the treatment of fractional shares. These statements are based on management’s current assumptions and are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. For other important factors that could cause actual results to differ materially from the forward-looking statements in this Current Report on Form 8-K, please see the risks and uncertainties identified under the heading “ Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as updated by the Company’s other filings with the SEC. All forward-looking statements reflect the Company’s beliefs and assumptions only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to update forward-looking statements to reflect future events or circumstances.

Item 9.01 Financial Statements and Exhibits.